2-Hydroxy Imiquimod | CAS 112668-45-8 - Request Quote
2-Hydroxy Imiquimod
| SZ CAT No: | SZ-I052017 |
| CAS No | 112668-45-8 |
| Mol.F. | C14H16N4O |
| Mol.Wt. | 256.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
2-Hydroxy Imiquimod is chemically 1-(4-Amino-1H-imidazo[4,5-c]quinolin-1-yl)-2-methylpropan-2-ol. 2-Hydroxy Imiquimod is supplied with detailed characterization data compliant with regulatory guideline. 2-Hydroxy Imiquimod can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Imiquimod.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 112668-45-8
Purchase 112668-45-8
Order 112668-45-8
Enquire 112668-45-8
price of 112668-45-8
112668-45-8 Supplier
112668-45-8 Manufacturer
112668-45-8 Exporter
buy high quality 2-Hydroxy Imiquimod
Purchase 2-Hydroxy Imiquimod
2-Hydroxy Imiquimod suppliers
2-Hydroxy Imiquimod manufacturers
2-Hydroxy Imiquimod price
Order 2-Hydroxy Imiquimod
Enquire 2-Hydroxy Imiquimod
2-Hydroxy Imiquimod cost
2-Hydroxy Imiquimod Supplier
2-Hydroxy Imiquimod Distributor
2-Hydroxy Imiquimod for Method Validation
Imiquimod Reference Standard
2-Hydroxy Imiquimod for ANDA Filing
2-Hydroxy Imiquimod for Forced Degradation Studies
2-Hydroxy Imiquimod Identification Standards
2-Hydroxy Imiquimod for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.